Phase
Condition
Peripheral Arterial Occlusive Disease
Coronary Artery Disease
Thrombosis
Treatment
POBA standard balloon
MagicTouch PTA sirolimus drug coated balloon (DCB)
Clinical Study ID
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 21 years or minimum age
Rutherford class 3 to 6 in the target limb Intraoperative Inclusion Criteria
Single or sequential de novo or re-stenotic lesions (stenosis of > 50% orocclusions) from 2 to 20cm in the femoropopliteal arteries. Lesion is considered asone lesion if there is maximum of 30mm gap between lesions at discretion ofinvestigator. Femoropopliteal arteries are superficial femoral artery, poplitealartery P1 and P2
Inflow free from flow limiting lesions (<50% stenosis) confirmed by duplex orangiography. Subjects with flow limiting inflow lesions (>50% stenosis) can beincluded if lesion had been treated successfully (<30% residual stenosis) before orduring the index procedure.
At least one non-occluded crural vessel (ie. without significant stenosis) withangiographically documented run off to the foot.
Exclusion
Exclusion Criteria:
Comorbid conditions limiting life expectancy ≤ 1 year
Subject is currently participating in another investigational drug or device studythat has not reached first primary endpoint yet
Subject is pregnant or planning to become pregnant during the course of the study
Heel gangrene
Prior bypass surgery of target vessel
Planned amputation of the target limb
Previously implanted stent in the target lesion
Vulnerable or protected adults
Bleeding diathesis or another disorder such as gastrointestinal ulceration whichrestrict the use of clopidogrel or aspirin
Known allergy to sirolimus Intraoperative Exclusion Criteria
Failure to successfully cross the target lesion with a guide wire (successfulcrossing means tip of the guide wire distal to the target lesion in the absence offlow limiting dissections or perforations)
Failure to obtain <30% residual stenosis in a pre-existing lesion
Highly calcific lesions
Use of DCBs, drug eluting stent, specialty balloons or artherectomy devices duringthe index procedure. (Non-compliant balloons are not considered specialty balloons)
Lesions requiring retrograde access (SAFARI)
Study Design
Study Description
Connect with a study center
Asan Medical Centre
Seoul,
Korea, Republic ofSite Not Available
Khoo Teck Puat Hospital
Singapore,
SingaporeActive - Recruiting
National University Hospital
Singapore,
SingaporeActive - Recruiting
Ng Teng Fong General Hospital
Singapore,
SingaporeSite Not Available
Sengkang General Hospital
Singapore,
SingaporeActive - Recruiting
Singapore General Hospital
Singapore,
SingaporeActive - Recruiting
Tan Tock Seng Hospital
Singapore,
SingaporeActive - Recruiting
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung,
TaiwanActive - Recruiting
Kaoshiung Chang Gung Memorial Hospital
Kaohsiung,
TaiwanActive - Recruiting
Far Eastern Memorial Hospital
New Taipei City,
TaiwanActive - Recruiting
Taipei Tzuchi Hospital
New Taipei City,
TaiwanActive - Recruiting
China Medical University Hospital
Taichung,
TaiwanSite Not Available
National Taiwan University Hospital
Taipei City,
TaiwanActive - Recruiting
Shin Kong Wu Ho-Su Memorial Hospital
Taipei City,
TaiwanActive - Recruiting
Taipei Mackay Memorial Hospital
Taipei City,
TaiwanSite Not Available
Linkou Chang Gung Memorial Hospital
Taoyuan City,
TaiwanActive - Recruiting
Phramongkutklao Hospital
Bangkok,
ThailandActive - Recruiting
Rajavithi Hospital
Bangkok,
ThailandActive - Recruiting
Ramathibodi Hospital
Bangkok,
ThailandSite Not Available
Siriraj Hospital
Bangkok,
ThailandActive - Recruiting
Vajira Hospital
Bangkok,
ThailandActive - Recruiting
Thammasat University Hospital
Pathumthani,
ThailandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.